Eastern Canadian Colorectal Cancer Consensus Conference: Standards of Care for the Treatment of Patients with Rectal, Pancreatic, and Gastrointestinal Stromal Tumours and Pancreatic Neuroendocrine Tumours

• DOI: 10.3747/co.20.1638
• Publication Date: 2013-10-22T18:47:18Z
• Authors: T. Di Valentin; J. Biagi; S. Bourque; R. Butt; P. Champion; V. Chaput; B. Colwell; C. Cripps; M. Dorreen; S. Edwards; C. Falkson; D. Frechette; S. Gill; R. Goel; D. Grant; N. Hammad; A. Jeyakumar; M. L’Espérance; C. Marginean; J. Maroun; M. Nantais; N. Perrin; C. Quinton; M. Rother; B. Samson; J. Siddiqui; S. Singh; S. Snow; E. St-Hilaire; M. Tehfe; M. Thirlwell; S. Welch; L. Williams; F. Wright; R. Goodwin
• Keywords: FOLFIRINOX

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Halifax, Nova Scotia, October 20-22, 2011. Health care professionals involved the of patients with colorectal cancer participated presentation and discussion sessions for purposes developing recommendations presented here. This consensus statement addresses current issues management rectal cancer, including pathology reporting, neoadjuvant systemic radiation therapy, surgical techniques, palliative patients. Other topics discussed include multidisciplinary conferences, treatment gastrointestinal stromal tumours pancreatic neuroendocrine tumours, use folfirinox stage ii colon cancer.